Danaher (DHR) Completes $9.9B Acquisition of Masimo Corporation

Danaher views this integration arsenic a strategical determination to heighten its diagnostics portfolio, specifically targeting acute attraction settings done Masimo's sensor and AI-monitoring technologies. The institution expects the acquisition to accelerate Masimo's planetary scope and supply caller capabilities for delivering specialized healthcare products.

Regarding fiscal impact, Danaher Corporation's (NYSE:DHR) existent 2026 guidance remains unchanged for the 2nd quarter, arsenic Masimo is not expected to lend materially until aboriginal successful the year. The institution plans to supply updated full-year 2026 fiscal guidance during its second-quarter net merchandise to bespeak the caller addition.

Danaher Corporation (NYSE:DHR) is simply a subject and exertion innovator that offers medical, research, and concern products and services, with an accent connected biotechnology, beingness sciences, and diagnostics. Operating done its subsidiaries, it delivers assorted solutions, including precocious testing, bioprocessing technologies, compartment civilization media improvement services, filtration technologies, and more.

While we admit the imaginable of DHR arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.